About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Tlr2
toll-like receptor 2
MGI:1346060
121 phenotypes from 4 alleles in 13 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Tlr2lngd/Tlr2lngd
C57BL/6J-Tlr2lngd 		abnormal macrophage physiology J:94077
increased susceptibility to bacterial infection J:94077
Tlr2tm1Aki/Tlr2tm1Aki
B6.129P2-Tlr2tm1Aki 		abnormal airway responsiveness J:147534
abnormal astrocyte morphology J:129957
abnormal body fat mass J:158035
abnormal circadian behavior J:247895
abnormal circulating cholesterol level J:158035
abnormal circulating glucose level J:158035
abnormal circulating insulin level J:158035
abnormal circulating LDL cholesterol level J:158035
abnormal circulating lipid level J:158035
abnormal dendritic cell physiology J:118954
abnormal glucose homeostasis J:158035
abnormal interleukin level J:118954
abnormal locomotor activation J:247895
abnormal locomotor circadian rhythm J:247895
abnormal neuron differentiation J:129957
abnormal pancreatic beta cell morphology J:148283
abnormal respiratory system physiology J:98456, J:147534
abnormal white fat cell size J:158035
normal behavior/neurological phenotype J:247895
decreased body weight J:247895
decreased cerebral infarct size J:122281
decreased circulating VLDL cholesterol level J:158035
decreased interleukin-6 secretion J:118954
decreased interleukin-12b secretion J:118954
decreased liver tumor incidence J:143870
decreased lung tumor incidence J:143870
decreased susceptibility to kidney reperfusion injury J:101532
decreased susceptibility to parasitic infection J:116763
normal growth/size/body region phenotype J:158035
hepatic steatosis J:158035
normal homeostasis/metabolism phenotype J:247895
increased circulating free fatty acids level J:158035
increased T cell number J:118954
small pancreatic islets J:148283
Tlr2tm1Aki/Tlr2tm1Aki
C.129P2-Tlr2tm1Aki 		normal immune system phenotype J:178054
Tlr2tm1Aki/Tlr2tm1Aki
involves: 129P2/OlaHsd 		abnormal cytokine secretion J:70578
abnormal hepatocyte morphology J:135830
abnormal leukocyte migration J:171379
abnormal macrophage physiology J:70578, J:103464, J:130138
abnormal osteoclast physiology J:130138
abnormal response to cardiac infarction J:119941
decreased cerebral infarct size J:128966
decreased circulating alanine transaminase level J:135830
decreased circulating interleukin-1 beta level J:119941
decreased circulating tumor necrosis factor level J:119941
decreased inflammatory response J:146111
decreased interleukin-6 secretion J:70578
decreased interleukin-12 secretion J:70578
decreased susceptibility to bacterial infection induced morbidity/mortality J:146111
decreased tumor necrosis factor secretion J:70578, J:103395
increased B cell apoptosis J:135830
normal muscle phenotype J:116310
Tlr2tm1Aki/Tlr2tm1Aki
involves: 129P2/OlaHsd * C57BL/6 		abnormal astrocyte physiology J:122551
abnormal chemokine level J:88174
abnormal glial cell physiology J:122551
abnormal glucose homeostasis J:124334
abnormal heart morphology J:103019
abnormal heart ventricle morphology J:103019
abnormal locomotor behavior J:122597
abnormal macrophage physiology J:76115, J:95726
abnormal response to cardiac infarction J:103019
abnormal tumor necrosis factor level J:124334
cardiac interstitial fibrosis J:103019
decreased heart left ventricle weight J:103019
decreased heart weight J:103019
decreased immunoglobulin level J:95726
decreased interleukin-6 secretion J:76115, J:88174
decreased lung weight J:103019
decreased microglial cell activation J:122551
decreased susceptibility to Herpesvirales infection J:88174
decreased susceptibility to Herpesvirales infection induced morbidity/mortality J:88174
decreased thermal nociceptive threshold J:122551
decreased tumor necrosis factor secretion J:76115
hyperresponsive to tactile stimuli J:122551
normal immune system phenotype J:76115
increased susceptibility to bacterial infection J:95726
normal nervous system phenotype J:99051
Tlr2tm1Aki/Tlr2tm1Aki
NOD.129P2-Tlr2tm1Aki 		abnormal glucose homeostasis J:124334
insulitis J:124334
Tlr2tm1Dgen/Tlr2tm1Dgen
involves: 129S1/Sv * C57BL/6 		no abnormal phenotype detected J:101679
Tlr2tm1Kir/Tlr2tm1Kir
B6.129-Tlr2tm1Kir 		abnormal cellular extravasation J:171028
abnormal cytokine secretion J:121930
abnormal enterocyte morphology J:128329
abnormal glucose homeostasis J:162168
abnormal intestinal epithelium morphology J:165105
abnormal large intestine crypts of Lieberkuhn morphology J:165105
brain ischemia J:148091
colonic necrosis J:165105
decreased angiogenesis J:171028
decreased cerebral infarct size J:124100
decreased circulating insulin level J:162168
decreased circulating leptin level J:162168
decreased circulating tumor necrosis factor level J:162168
decreased fat cell size J:162168
decreased gonadal fat pad weight J:162168
decreased interleukin-1 beta secretion J:129871
decreased interleukin-6 secretion J:129871
decreased neuron apoptosis J:124100
decreased splenocyte proliferation J:121930
decreased susceptibility to bacterial infection induced morbidity/mortality J:121930
decreased susceptibility to hepatic steatosis J:162168
decreased susceptibility to kidney reperfusion injury J:146120
decreased tumor necrosis factor secretion J:129871
improved glucose tolerance J:162168
increased adipocyte glucose uptake J:162168
increased carcinoma incidence J:165105
increased colon adenoma incidence J:165105
increased energy expenditure J:162168
increased food intake J:162168
increased gastrointestinal tumor incidence J:165105
increased insulin secretion J:162168
increased insulin sensitivity J:162168
increased susceptibility to induced colitis J:165105
premature death J:128329, J:165105
rectal hemorrhage J:128329, J:165105
weight loss J:128329, J:165105
Tlr2tm1Kir/Tlr2tm1Kir
C.129(B6)-Tlr2tm1Kir/Tvg 		normal neoplasm J:329456
Tlr2tm1Kir/Tlr2tm1Kir
either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * C57BL/6J) 		abnormal innate immunity J:85323
abnormal macrophage physiology J:85323
decreased interleukin-6 secretion J:85323
decreased interleukin-10 secretion J:85323
decreased macrophage cytokine production J:85323
decreased macrophage nitric oxide production J:85323
increased susceptibility to bacterial infection J:85323
Tlr2tm1Kir/Tlr2tm1Kir
involves: 129 		abnormal adrenal cortex morphology J:94463
abnormal adrenal gland morphology J:94463
abnormal adrenal gland secretion J:94463
abnormal circulating corticosterone level J:94463
abnormal circulating pituitary hormone level J:94463
abnormal endoplasmic reticulum morphology J:94463
abnormal interleukin secretion J:94463
abnormal mitochondrial morphology J:94463
abnormal mitochondrial shape J:94463
decreased circulating corticosterone level J:94463
decreased interleukin-1 secretion J:94463
decreased interleukin-6 secretion J:94463
decreased mitochondrial number J:94463
decreased tumor necrosis factor secretion J:94463
enlarged adrenal glands J:94463
increased circulating adrenocorticotropin level J:94463
increased susceptibility to bacterial infection induced morbidity/mortality J:147177
Tlr2tm1Kir/Tlr2tm1Kir
involves: 129 * C57BL/6 		abnormal myelination J:161285
Tlr2tm1Kir/Tlr2tm1Kir
Not Specified 		abnormal macrophage physiology J:96018
increased susceptibility to bacterial infection J:96018
increased susceptibility to induced morbidity/mortality J:96018
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/19/2024
MGI 6.24 		The Jackson Laboratory